Abstract:It has long been asserted that failure to recover from central nervous system diseases is due to the system’s intricate structure and the regenerative incapacity of adult neurons. Yet over recent decades, numerous studies have established that endogenous neurogenesis occurs in the adult central nervous system, including humans’. This has challenged the long-held scientific consensus that the number of adult neurons remains constant, and that new central nervous system neurons cannot be created or renewed. Herein, we present a comprehensive overview of the alterations and regulatory mechanisms of endogenous neurogenesis following central nervous system injury, and describe novel treatment strategies that target endogenous neurogenesis and newborn neurons in the treatment of central nervous system injury. Central nervous system injury frequently results in alterations of endogenous neurogenesis, encompassing the activation, proliferation, ectopic migration, differentiation, and functional integration of endogenous neural stem cells. Because of the unfavorable local microenvironment, most activated neural stem cells differentiate into glial cells rather than neurons. Consequently, the injury-induced endogenous neurogenesis response is inadequate for repairing impaired neural function. Scientists have attempted to enhance endogenous neurogenesis using various strategies, including using neurotrophic factors, bioactive materials, and cell reprogramming techniques. Used alone or in combination, these therapeutic strategies can promote targeted migration of neural stem cells to an injured area, ensure their survival and differentiation into mature functional neurons, and facilitate their integration into the neural circuit. Thus can integration replenish lost neurons after central nervous system injury, by improving the local microenvironment. By regulating each phase of endogenous neurogenesis, endogenous neural stem cells can be harnessed to promote effective regeneration of newborn neurons. This offers a novel approach for treating central nervous system injury.

Reprogramming Glial Cells into Functional Neurons for Neuro-regeneration: Challenges and Promise

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Progress of Reprogramming Astrocytes into Neuron

Stem Cells for the Treatment of Neurodegenerative Diseases

Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury.

A Promise for Neuronal Repair: Reprogramming Astrocytes into Neurons in Vivo

The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders

Reprogramming Astrocytes to Motor Neurons by Activation of Endogenous Ngn2 and Isl1

In situ Chemical Reprogramming of Astrocytes into Neurons: A New Hope for the Treatment of Central Neurodegenerative Diseases?

Direct Conversion of Somatic Cells into Induced Neurons

Direct Cell Reprogramming and Phenotypic Conversion: An Analysis of Experimental Attempts to Transform Astrocytes into Neurons in Adult Animals

Reprogrammed Astrocytes As a Potential Therapy for Neurodegenerative Disorders.

Neuronal conversion from glia to replenish the lost neurons

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions.

Challenges and Efficacy of Astrocyte-to-Neuron Reprogramming in Spinal Cord Injury: In Vitro Insights and In Vivo Outcomes

Direct Lineage Reprogramming to Neural Cells

Improving Efficiency of Direct Pro-Neural Reprogramming: Much-Needed Aid for Neuroregeneration in Spinal Cord Injury

Precise Integration of Direct Cell Reprogramming-Induced Neuronal Cells into Adult Neocortical Circuits

Decoding single-cell molecular mechanisms in astrocyte-to-iN reprogramming via Ngn2- and Pax6-mediated direct lineage switching

A core scientific problem in the treatment of central nervous system diseases: newborn neurons

Neurogenic Niche Conversion Strategy Induces Migration and Functional Neuronal Differentiation of Neural Precursor Cells Following Brain Injury